TNXP Tonix Pharmaceuticals Holding Corp.: Net Asset Value
This price chart helps track the environmental status of Tonix Pharmaceuticals (TNXP), which is limited to formal compliance with disposal regulations. The business model relies on full production outsourcing via CMOs, shifting the focus toward patents and R&D. Meanwhile, Tonix Pharmaceuticals (TNXP) is developing a diversified portfolio of treatments for PTSD, pain, and viruses, achieving the 0.23 metric, which increases the probability of commercial success for its developments.
TNXP (Tonix Pharmaceuticals Holding Corp.): analytical breakdowns and indicator data
The complex drug development process and patent battles of Tonix Pharmaceuticals (TNXP) are reflected in the history of its book capitalization changes. This indicator captures the dynamics of net asset value minus all liabilities. The calculation is based on daily quotes, forming an objective series of the capital's fundamental evolution. Fluctuations in market valuations around this figure determine the risk of overpaying for or undervaluing the asset. This tool characterizes a speculative class of securities.